Structural changes in lysosomes from cultured human fibroblasts in Duchenne's muscular dystrophy
- PMID: 6782112
- PMCID: PMC2111753
- DOI: 10.1083/jcb.88.2.329
Structural changes in lysosomes from cultured human fibroblasts in Duchenne's muscular dystrophy
Abstract
We have previously reported a decreased activity of the lysosomal enzyme dipeptidyl aminopeptidase-I (DAP-I) in cultured fibroblasts from patients with Duchenne's muscular dystrophy (DMD). Here we report that electron microscope examination of these cells reveals the presence of abundant lamellar bodies, a morphologic abnormalities commonly associated with impaired lysosomal function. Morphometric analysis of these cytoplasmic figures in dystrophic cells shows a sevenfold increase relative to normal controls (P less than 0.01). Analysis of lysosomal density profiles by density gradient centrifugation reveals similar patterns in normal and DMD cells. Treatment of lysosomes wit the nonionic detergent Triton X-100 causes an activation of DAP-I. This activation, attributable to structure-linked latency, is markedly diminished in DMD cells which show an optimal activation of only 180% compared to 255% for control fibroblasts (P less than 0.01). These data suggest an alteration in the properties of the lysosomal membrane in DMD fibroblasts. This suggestion is also supported by studies on the release of DAP-I from lysosomes by osmotic shock which show it to be a membrane-associated enzyme with membrane-binding characteristics intermediate between those of tightly bound beta-glucosidase and those of unbound N-acetylgalactosaminidase. The latency characteristics of these other lysosomal enzymes are not altered in the DMD cells, indicating that the effect is specific for DAP-I.
Similar articles
-
Decreased lysosomal dipeptidyl aminopeptidase I activity in cultured human skin fibroblasts in Duchenne's muscular dystrophy.J Clin Invest. 1980 Jun;65(6):1398-406. doi: 10.1172/JCI109804. J Clin Invest. 1980. PMID: 6773986 Free PMC article.
-
Decreased structure-linked latency of lysosomal dipeptidyl aminopeptidase-I activity in Duchenne muscular dystrophy fibroblasts.Neurology. 1982 May;32(5):486-91. doi: 10.1212/wnl.32.5.486. Neurology. 1982. PMID: 7200205
-
Identification of a biochemical difference between male and female human fibroblasts: implications for the expression of Duchenne muscular dystrophy.Neurology. 1982 Sep;32(9):951-7. doi: 10.1212/wnl.32.9.951. Neurology. 1982. PMID: 7202167
-
Muscular dystrophy and activation of proteinases.Muscle Nerve. 1978 Jul-Aug;1(4):308-13. doi: 10.1002/mus.880010407. Muscle Nerve. 1978. PMID: 35747 Review.
-
Leber's congenital amaurosis with Duchenne's muscular dystrophy.Can J Ophthalmol. 1990 Jun;25(4):202-7. Can J Ophthalmol. 1990. PMID: 1972344 Review.
Cited by
-
Changes of lysosomes in the earliest stages of the development of atherosclerosis.J Cell Mol Med. 2013 May;17(5):626-35. doi: 10.1111/jcmm.12042. Epub 2013 Mar 14. J Cell Mol Med. 2013. PMID: 23490339 Free PMC article.
-
PGC-1α overexpression increases transcription factor EB nuclear localization and lysosome abundance in dystrophin-deficient skeletal muscle.Physiol Rep. 2020 Feb;8(4):e14383. doi: 10.14814/phy2.14383. Physiol Rep. 2020. PMID: 32109352 Free PMC article.
-
Reversible change in the fibroblast lysosomal enzyme dipeptidyl aminopeptidase-1 (cathepsin C) related to the commercial source of fetal bovine serum in the culture medium.In Vitro Cell Dev Biol. 1985 Jun;21(6):340-6. doi: 10.1007/BF02691582. In Vitro Cell Dev Biol. 1985. PMID: 3894318
-
Increased membrane permeability to chloride in Duchenne muscular dystrophy fibroblasts and its relationship to muscle function.Proc Natl Acad Sci U S A. 1983 Aug;80(15):4732-6. doi: 10.1073/pnas.80.15.4732. Proc Natl Acad Sci U S A. 1983. PMID: 6576355 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous